8039 — TAIFLEX Scientific Co Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedSmall CapContrarian

Annual cashflow statement for TAIFLEX Scientific Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	966	941	877	482	701
Depreciation
Amortisation
Non-Cash Items	44.7	84.6	185	94.7	192
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-212	-1,194	-352	236	-1.75
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,133	228	1,142	1,272	1,421
Capital Expenditures	-551	-529	-977	-1,015	-693
Purchase of Fixed Assets
Other Investing Cash Flow Items	348	-543	289	30.5	267
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-203	-1,072	-688	-985	-426
Financing Cash Flow Items	-216	19.8	4.44	15.7	-14.3
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,723	2,306	-1,512	-568	-165
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-791	1,477	-1,006	-299	924